The role of NIH in drug development innovation and its impact on patient access proceedings of a workshop

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC....

Descripción completa

Detalles Bibliográficos
Autor principal: Amankwah, Francis (-)
Autores Corporativos: National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Health Care Services, organizador (organizador), National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Health Sciences Policy, organizador (-), Workshop on the Role of NIH in Drug Development Innovation and Its Impact on Patient Access
Otros Autores: Andrada, Alexandra, Nass, Sharyl J., Wizemann, Theresa M.
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, DC : National Academies Press [2020]
Colección:National Academies ebooks.
Acceso en línea:Conectar con la versión electrónica
Ver en Universidad de Navarra:https://innopac.unav.es/record=b4494729x*spi
Descripción
Sumario:To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Descripción Física:1 recurso electrónico (xvi, 85 páginas) : ilustraciones
Formato:Forma de acceso: World Wide Web.
Bibliografía:Incluye referencias bibliográficas.
ISBN:9780309498517